Thursday, December 10, 2015 8:26:31 PM
We are all speculating, but NW deliberately trying to intentionally harm or take over NWBO...
Perhaps this maybe a new thriller courtesy of the times or the baptism by fire this NWBO experience has engendered for 95% here with those lacking direct past experience with DeepCapture chronicles.
I do NOT find plausibility in ANY of the newfangled EXTREMIST views ie Afford/DoGood_DoWell & others of a smoking gun agenda of Woodford's investment position for the following logical reasons:
Neil Woodford does NOT need to do things in a veiled manner. He is not a product of a millennial generation of Tom Clancy thriller novels etc.
He already has demonstrated his track record of results over DECADES.
Besides NWBO is still a small position of Woodford Investment Mgt despite his $180 mln investment being under water.
Moreover, ONDRA Ptnrs is more of the GREED side vs that of Neil Woodford which is the ultimate distinction EVERYONE here needs to distinguish and separate versus pool. IBK types are SO DIFFERENT than Buffet like types like Woodford based on my exposure and experience..
Did any one really think that CEO Linda Powers would acquiesce without modification to the reasonable demands by influential, heavyweight shareholder Neil Woodford? Two Titans, one having earned and demonstrated it, and the other still struggling in her last mile.... I have not been surprised like others that have posted with trepidation (look at those alarmist posts!) as BOTH can reach a MUTUALLY satisfactory agreement despite the pressures on both sides. And assigning to Neil Woodford those superfluous fictionals and behind the scene theatricals is IMHO pure
soap opera given Woodford's ATTAINED stature.
HOWEVER, when IP and Confidential Proprietary Information has been subject to theft? then THERE IS TOO MUCH AT RISK OF WHAT SHE HAS SPENT MOST OF HER LAST DECADE STRUGGLING WITH FORMIDABLE OBSTACLES.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
